Juárez, A.; Salas, M.Q.; Pedraza, A.; Suárez-Lledó, M.; RodrÃguez-Lobato, L.G.; Solano, M.T.; Serrahima, A.; Nomdedeu, M.; Cid, J.; Lozano, M.;
et al. Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study. Cancers 2024, 16, 2567.
https://doi.org/10.3390/cancers16142567
AMA Style
Juárez A, Salas MQ, Pedraza A, Suárez-Lledó M, RodrÃguez-Lobato LG, Solano MT, Serrahima A, Nomdedeu M, Cid J, Lozano M,
et al. Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study. Cancers. 2024; 16(14):2567.
https://doi.org/10.3390/cancers16142567
Chicago/Turabian Style
Juárez, Alex, MarÃa Queralt Salas, Alexandra Pedraza, MarÃa Suárez-Lledó, LuÃs Gerardo RodrÃguez-Lobato, MarÃa Teresa Solano, Anna Serrahima, Meritxell Nomdedeu, Joan Cid, Miquel Lozano,
and et al. 2024. "Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study" Cancers 16, no. 14: 2567.
https://doi.org/10.3390/cancers16142567
APA Style
Juárez, A., Salas, M. Q., Pedraza, A., Suárez-Lledó, M., RodrÃguez-Lobato, L. G., Solano, M. T., Serrahima, A., Nomdedeu, M., Cid, J., Lozano, M., Charry, P., Arcarons, J., Llobet, N., Rosiñol, L., Fernández-Avilés, F., Rovira, M., & MartÃnez, C.
(2024). Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study. Cancers, 16(14), 2567.
https://doi.org/10.3390/cancers16142567
